Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2013 1
2014 3
2015 3
2016 1
2017 1
2019 1
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 in Light of Seasonal Respiratory Infections.
Kiseleva I, Grigorieva E, Larionova N, Al Farroukh M, Rudenko L. Kiseleva I, et al. Among authors: larionova n. Biology (Basel). 2020 Aug 20;9(9):240. doi: 10.3390/biology9090240. Biology (Basel). 2020. PMID: 32825427 Free PMC article. Review.
Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.
Rudenko L, van den Bosch H, Kiseleva I, Mironov A, Naikhin A, Larionova N, Bushmenkov D. Rudenko L, et al. Among authors: larionova n. Vaccine. 2011 Jul 1;29 Suppl 1:A40-4. doi: 10.1016/j.vaccine.2011.04.122. Vaccine. 2011. PMID: 21684428 Free article. Review.
Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells.
Shcherbik S, Pearce N, Carney P, Bazhenova E, Larionova N, Kiseleva I, Rudenko L, Kumar A, Goldsmith CS, Dugan V, Stevens J, Wentworth DE, Bousse T. Shcherbik S, et al. Among authors: larionova n. Vaccine X. 2019 Jun 19;2:100031. doi: 10.1016/j.jvacx.2019.100031. eCollection 2019 Aug 9. Vaccine X. 2019. PMID: 31384746 Free PMC article.
A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults.
Kiseleva I, Isakova-Sivak I, Stukova M, Erofeeva M, Donina S, Larionova N, Krutikova E, Bazhenova E, Stepanova E, Vasilyev K, Matyushenko V, Krylova M, Galatonova J, Ershov A, Lioznov D, Sparrow EG, Torelli G, Rudenko L. Kiseleva I, et al. Among authors: larionova n. Vaccines (Basel). 2020 Jun 10;8(2):296. doi: 10.3390/vaccines8020296. Vaccines (Basel). 2020. PMID: 32532097 Free PMC article.
Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study.
Rudenko L, Kiseleva I, Stukova M, Erofeeva M, Naykhin A, Donina S, Larionova N, Pisareva M, Krivitskaya V, Flores J; Russian LAIV Trial Study Group. Rudenko L, et al. Among authors: larionova n. Vaccine. 2015 Sep 22;33(39):5110-7. doi: 10.1016/j.vaccine.2015.08.019. Epub 2015 Aug 19. Vaccine. 2015. PMID: 26296497 Clinical Trial.
Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.
Rudenko L, Kiseleva I, Naykhin AN, Erofeeva M, Stukova M, Donina S, Petukhova G, Pisareva M, Krivitskaya V, Grudinin M, Buzitskaya Z, Isakova-Sivak I, Kuznetsova S, Larionova N, Desheva J, Dubrovina I, Nikiforova A, Victor JC, Neuzil K, Flores J, Tsvetnitsky V, Kiselev O. Rudenko L, et al. Among authors: larionova n. PLoS One. 2014 Feb 12;9(2):e87962. doi: 10.1371/journal.pone.0087962. eCollection 2014. PLoS One. 2014. PMID: 24533064 Free PMC article. Clinical Trial.
13 results